5 European Projects Found
Searched on 125080 European Projects
FINISHED
Targeting novel lipid pathways for treatment of cardiovascular disease (Athero-Flux)
Start date: Sep 1, 2013, End date: Aug 31, 2018,
Lipid lowering has significantly reduced cardiovascular disease (CVD) mortality in EU. However, the aim to abolish CVD in EU is far from achieved and attempts to improve on the benefits of statins with new agents have not yet delivered new therapeutics. The Consortium Athero-Flux builds on FP7-generated large-scale lipidomics data showing that specific sphingolipids and in particular distinct cer ...
Read Project
12
Partners Participants
FINISHED
Personalized diagnostics and treatment of high risk coronary artery disease patients (RISKYCAD)
Start date: Nov 1, 2012, End date: Oct 31, 2017,
Although the accurate diagnosis and prevention of coronary artery disease (CAD), acute myocardial infarction (AMI) and death is a major public health issue, risk stratification for CAD with current diagnostic tools is not properly supporting clinical decision making. RiskyCAD’s overall goal is to identify novel biomarkers for asymptomatic patients in high risk of major coronary events, and develop ...
Read Project
12
Partners Participants
FINISHED
European Collaborative Project on Inflamation and Vascular Wall Remodelling in Atherosclerosis (ATHEROREMO)
Start date: May 1, 2008, End date: Oct 31, 2013,
"The health of the EC population has never been better. However, serious public health problems remain, which cannot be ignored including high levels of premature death due to cardiovascular diseases. Thus, new preventive, diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases are needed. The atherosclerotic changes of the vascular wall are central in the developmen ...
Read Project
19
Partners Participants
FINISHED
Lipid droplets as dynamic organelles of fat deposition and release: Translational research towards human disease (LipidomicNet)
Start date: May 1, 2008, End date: Oct 31, 2012,
Lipids are central to the regulation and control of cellular processes by acting as basic building units for biomembranes, the platforms for the vast majority of cellular functions. Recent developments in lipid mass spectrometry have set the scene for a completely new way to understand the composition of membranes, cells and tissues in space and time by allowing the precise identification and quan ...
Read Project
27
Partners Participants
FINISHED
"DIAbetes type 1 PRediction, Early Pathogenesis and Prevention" (DIAPREPP)
Start date: Apr 1, 2008, End date: Aug 31, 2011,
"The earliest currently identifiable process in the pathogenesis of type 1 diabetes (T1D) is the development of autoimmunity to islet beta cells in the form of autoantibodies. Hindering attempts to prevent autoimmune T1D, the aetiology and pathogenesis of the islet auto-immunization, including whether it is preceded by metabolic abnormalities and cell-mediated autoimmunity, is still poorly underst ...
Read Project
